Results 81 to 90 of about 1,368 (177)

Lope de Vega

Atenea (Concepción), 1935
openaire   +2 more sources

Lope de Vega. La vega del Parnaso

BOLETÍN DE LA BIBLIOTECA DE MENÉNDEZ PELAYO, 2018
.
openaire   +1 more source

Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru. [PDF]

Microbiol Resour Announc, 2020
Padilla-Rojas C, Lope-Pari P, Vega-Chozo K, Balbuena-Torres J, Caceres-Rey O, Bailon-Calderon H, Huaringa-Nuñez M, Rojas-Serrano N.   +7 more
europepmc   +1 more source

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study. [PDF]

Drugs Real World Outcomes, 2020
Szerman N, Basurte-Villamor I, Vega P, Martinez-Raga J, Parro-Torres C, Cambra Almerge J, Grau-López L, De Matteis M, Arias F.   +8 more
europepmc   +1 more source

GATA3 as a Blood-Based RNA Biomarker for Idiopathic Parkinson's Disease. [PDF]

Int J Mol Sci, 2023
Acharya S, Lumley AI, Zhang L, Vausort M, Devaux Y, On Behalf Of The Ncer-Pd Consortium.   +5 more
europepmc   +1 more source

Exploring the adjustment to parasite pressure hypothesis: differences in uropygial gland volume and haemosporidian infection in palearctic and neotropical birds. [PDF]

Curr Zool, 2021
Magallanes S, Møller AP, Luján-Vega C, Fong E, Vecco D, Flores-Saavedra W, García-Longoriaa L, de Lope F, Iannacone JA, Marzal A.   +9 more
europepmc   +1 more source

Author Correction: Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson's disease. [PDF]

NPJ Digit Med
Brzenczek C, Klopfenstein Q, Hähnel T, Sapienza S, Klucken J, Fröhlich H, Glaab E, NCER-PD Consortium.   +7 more
europepmc   +1 more source

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment. [PDF]

Neuropsychiatr Dis Treat, 2022
Basurte-Villamor I, Vega P, Vega P, Roncero C, Martínez-Raga J, Grau-López L, Aguilar L, Torrens M, Szerman N.   +8 more
europepmc   +1 more source

Data-driven clinical decision support tool for diagnosing mild cognitive impairment in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Martínez Tirado G, Martins Conde P, Sapienza S, Fröhlich H, Pauly C, Schröder VE, Jónsdóttir S, Tsurkalenko O, Krüger R, Klucken J, NCER-PD consortium.   +10 more
europepmc   +1 more source

Penetrance of Parkinson's disease in GBA1 carriers depends on variant severity and polygenic background. [PDF]

NPJ Parkinsons Dis
Hassanin E, Landoulsi Z, Pachchek S, NCER-PD Consortium, Krawitz P, Maj C, Krüger R, May P, Bobbili DR.   +8 more
europepmc   +1 more source